The Effect of Therapy Combination in PCOS With Dlbs 3233
NCT07403201
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
90
Enrollment
OTHER
Sponsor class
Conditions
Polycystic Ovary Syndrome
Interventions
COMBINATION_PRODUCT:
dlbs 3233 , clomifen citrat
Sponsor
Inlacinpenelitian